Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Seminars in Cancer Biology

• Publication date

  2000-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/SCBI.2000.0314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways

  2000cited by this paper
• Gene Transfer of IFN-γ into Established Brain Tumors Represses Growth by Antiangiogenesis

  2000cited by this paper
• CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ

  1999cited by this paper
• Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor β

  1999cited by this paper
• Interactions Between Chemokines and Other Cytokines in Host Response to Tumor

  1999cited by this paper
• The paradigm of type 1 and type 2 antigen‐presenting cells. Implications for atopic allergy

  1999cited by this paper
• Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.

  1999cited by this paper
• Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo.

  1999cited by this paper
• Other functions, other genes: alternative activation of antigen-presenting cells.

  1999cited by this paper
• Genes regulating MHC class I processing of antigen

  1999cited by this paper
• Specificity of the proteasome and the TAP transporter.

  1999cited by this paper
• Lymphocyte trafficking and regional immunity.

  1999cited by this paper
• Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells.

  1999cited by this paper
• Antigen presentation by MHC class I and its regulation by interferon gamma.

  1999cited by this paper
• Loss of STAT1 expression confers resistance to IFN‐γ‐induced apoptosis in ME180 cells

  1999cited by this paper
• Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions

  1998cited by this paper
• Different Requirements for Signal Transducer and Activator of Transcription 1α and Interferon Regulatory Factor 1 in the Regulation of Low Molecular Mass Polypeptide 2 and Transporter Associated with Antigen Processing 1 Gene Expression*

  1998cited by this paper
• CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

  1998cited by this paper
• Tumor‐induced immune dysfunction: the macrophage connection

  1998cited by this paper
• Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer.

  1998cited by this paper
• Contribution of the CXC chemokines IP‐10 and Mig to the antitumor effects of IL‐12

  1998cited by this paper
• Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.

  1998cited by this paper
• The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.

  1998cited by this paper
• Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice

  1998cited by this paper
• Synergistic anti‐tumor effects with co‐expression of GM‐CSF and IFN‐γ in murine tumors

  1998cited by this paper
• Chemokines and leukocyte traffic

  1998cited by this paper
• Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review.

  1998cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• DAP genes: novel apoptotic genes isolated by a functional approach to gene cloning.

  1998cited by this paper
• The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.

  1998cited by this paper
• How do endogenous proteins become peptides and reach the endoplasmic reticulum.

  1998cited by this paper
• Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays

  1998cited by this paper
• How cells respond to interferons.

  1998cited by this paper
• The chemokine receptor CXCR3 mediates rapid and shear‐resistant adhesion‐induction of effector T lymphocytes by the chemokines IP10 and Mig

  1998cited by this paper
• The role of CXC chemokines in the regulation of angiogenesis in non‐small cell lung cancer

  1997cited by this paper
• Trafficking of activated lymphocytes into the RENCA tumour microcirculation in vivo in mice.

  1997cited by this paper
• The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.

  1997cited by this paper
• Potentiation of Interferon-Induced Indoleamine 2,3-Dioxygenase mRNA in Human Mononuclear Phagocytes by Lipopolysaccharide and Interleukin-1

  1997cited by this paper
• The IFN gamma receptor: a paradigm for cytokine receptor signaling.

  1997cited by this paper
• Nitric oxide in tumor biology and cancer therapy. Part 2: Therapeutic implications.

  1997cited by this paper
• Differentiation and functions of T cell subsets.

  1997cited by this paper
• Nitric oxide and macrophage function.

  1997cited by this paper
• Synergy between Interferon-γ and Tumor Necrosis Factor-α in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κB*

  1997cited by this paper
• Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.

  1997cited by this paper
• The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.

  1997cited by this paper
• Interferon-resistant Human Melanoma Cells Are Deficient in ISGF3 Components, STAT1, STAT2, and p48-ISGF3γ*

  1997cited by this paper
• Cytokines, tumour-cell death and immunogenicity: a question of choice.

  1997cited by this paper
• Cellular responses to interferon-gamma.

  1997cited by this paper
• Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis

  1997cited by this paper
• Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo

  1997cited by this paper
• Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.

  1996cited by this paper
• Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

  1996cited by this paper
• Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

  1996cited by this paper
• Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

  1996cited by this paper
• Activation of nitric oxide synthase gene for inhibition of cancer metastasis

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Interferons in melanoma.

  1996cited by this paper
• Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.

  1996cited by this paper
• Antitumor activity of interleukin 12 in preclinical models

  1996cited by this paper
• Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.

  1996cited by this paper
• Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.

  1996cited by this paper
• Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

  1996cited by this paper
• Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice.

  1996cited by this paper
• Molecular basis for lack of expression of HLA class I antigens in human small‐cell lung carcinoma cell lines

  1996cited by this paper
• Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12.

  1995cited by this paper
• Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

  1995cited by this paper
• Paracrine cytokine adjuvants in cancer immunotherapy.

  1995cited by this paper
• Interferon‐α and interferon‐γ down‐regulate the production of interleukin‐8 and ENA‐78 in human monocytes

  1995cited by this paper
• T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.

  1995cited by this paper
• Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration.

  1995cited by this paper
• Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

  1995cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter

  1995cited by this paper
• Roles of nitric oxide in tumor growth.

  1995cited by this paper
• Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor.

  1995cited by this paper
• Pathways for the processing and presentation of antigens to T cells

  1995cited by this paper
• The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation

  1995cited by this paper
• Expression and expressional control of nitric oxide synthases in various cell types.

  1995cited by this paper
• Signals and Receptors Involved in Recruitment of Inflammatory Cells (*)

  1995cited by this paper
• Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• Nitric oxide synthases: gene structure and regulation.

  1995cited by this paper
• A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

  1995cited by this paper
• Inhibition of angiogenesis in vivo by interleukin 12.

  1995cited by this paper
• IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, Pennsylvania

  1995cited by this paper
• THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS

  1995cited by this paper
• THE role of indoleamine 2,3‐dioxygenase in the anti‐tumour activity of human interferon‐γ in vivo

  1995cited by this paper
• Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

  1994cited by this paper
• Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.

  1994cited by this paper
• Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity.

  1994cited by this paper
• Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.

  1994cited by this paper
• Immunotherapy of cancer using cytokine gene-modified tumor vaccines.

  1994cited by this paper
• HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons.

  1994cited by this paper
• Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

  1994cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• Lymphocytes, cytokines, inflammation, and immune trafficking.

  1994cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• Microvascular expression of mala‐2 correlates with In vivo lymphocyte trafficking and is preferentially enhanced in tumors by tumor necrosis factor‐α and interleukin‐1α

  1994cited by this paper
• Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

  1994cited by this paper
• IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages.

  1994cited by this paper

• Evaluating CAR-T cells from neurofibromatosis type 1 (NF1) patients for targeting AXL in malignant peripheral nerve sheath tumors associated with NF1

  2025cites this paper
• Exploring the role of inflammation, immunity, and metabolism in colorectal cancer via mendelian randomization approach

  2025cites this paper
• Role of Surgical Pathologist for the Detection of Immuno-oncologic Predictive Factors in Non-small Cell Lung Cancers.

  2023cites this paper
• A Mendelian randomization study on the causal association of circulating cytokines with colorectal cancer

  2023cites this paper
• A Genetic Variant in CD274 Is Associated With Prognosis in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Based Chemotherapy

  2022cites this paper
• Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target

  2022cites this paper
• Evaluation and selection of a lead diabody for interferon-γ PET imaging.

  2022cites this paper
• Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers

  2022cites this paper
• Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization

  2022cites this paper
• Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling

  2022cites this paper
• Vaccines targeting angiogenesis in melanoma.

  2021cites this paper
• PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity

  2021cites this paper
• Simultaneous disruption of circulating miR‐21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC)

  2021cites this paper
• PD-L1 lncRNA splice promotes lung adenocarcinoma progression via enhancing c-Myc activity

  2020cites this paper
• Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events

  2019cites this paper
• Innate and Adaptive Immune Responses to Cancer

  2019cites this paper
• Low-dose IFN-γ induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer

  2019cites this paper
• Evaluation of ultra-low input RNA sequencing for the study of human T cell transcriptome

  2019cites this paper
• Low-dose IFN-γ induces tumor cell stemness in the tumor microenvironment of non-small cell lung cancer.

  2019cites this paper
• Biotinylated peptide nanofibers for modulating the immune response

  2016cites this paper
• Immunobiology of Emerging Human DNA Viruses

  2014cites this paper
• Lymphocyte responses to the polyphenol, oenothein B, and the influence of age on these responses

  2014cites this paper
• Charge-selective fractions of naturally occurring nanoparticles as bioactive nanocarriers for cancer therapy.

  2014cites this paper
• Innate and Adaptive Immune Responses to Cancer

  2014cites this paper
• Fallen Angels or Risen Apes? A Tale of the Intricate Complexities of Imbalanced Immune Responses in the Pathogenesis and Progression of Immune-Mediated and Viral Cancers

  2014cites this paper
• Bursin-like peptide (BLP) enhances H9N2 influenza vaccine induced humoral and cell mediated immune responses.

  2014cites this paper
• Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

  2014cites this paper
• delivery to the tumor blood vessel extracellular matrix Enhancement of the antitumor properties of interleukin-2 by its targeted

  2013cites this paper
• Oenothein B, a Cyclic Dimeric Ellagitannin Isolated from Epilobium angustifolium, Enhances IFNγ Production by Lymphocytes

  2012cites this paper
• The Dual Role of Inflammation in Colon Carcinogenesis

  2012cites this paper
• Trichodysplasia spinulosa-Associated Polyomavirus (TSV) and Merkel Cell Polyomavirus: Correlation between Humoral and Cellular Immunity Stronger with TSV

  2012cites this paper
• Predictive Value of IFN-γ-Induced Indoleamine 2,3-Dioxygenase (IDO) Expression in Cancer Patients

  2011cites this paper
• T-helper Cell-Mediated Proliferation and Cytokine Responses against Recombinant Merkel Cell Polyomavirus-Like Particles

  2011cites this paper
• Involvement of ERK and JNK pathways in IFN-γ-induced B7-DC expression on tumor cells

  2011cites this paper
• Interleukin-18-mediated interferon-gamma secretion is regulated by thymosin beta 4 in human NK cells.

  2011cites this paper
• IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production

  2011cites this paper
• Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?

  2010cites this paper
• Impact of γ-chain cytokines on EBV-specific T cell cultures

  2010cites this paper
• Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide.

  2009cites this paper
• Induction of apoptosis in tumor cells as a mechanism of tumor growth reduction in allergic mice.

  2009cites this paper
• Th1- and Th2-type cytokines in plasma after major trauma.

  2008cites this paper
• Optimierte Peptide und Peptidpools zur Stimulation antigenspezifischer T-Zellen bei Zytomegalievirus

  2008cites this paper
• Interferons at age 50: past, current and future impact on biomedicine

  2007cites this paper
• The "T" in trauma: the helper T-cell response and the role of immunomodulation in trauma and burn patients.

  2007cites this paper
• Pre‐clinical Evaluation of a CEA DNA Prime/protein Boost Vaccination Strategy Against Colorectal Cancer

  2007cites this paper
• Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy.

  2007cites this paper
• MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10.

  2007cites this paper
• Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver.

  2006cites this paper
• Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients

  2006cites this paper
• Arsenic trioxide synergizes with B7H3‐mediated immunotherapy to eradicate hepatocellular carcinomas

  2006cites this paper
• Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG.

  2006cites this paper
• Effects of human soluble BAFF synthesized in Escherichia coli on CD4+ and CD8+ T lymphocytes as well as NK cells in mice.

  2006cites this paper
• Simultaneous Induction of CD4 T Cell Tolerance and CD8 T Cell Immunity by Semimature Dendritic Cells1

  2005cites this paper
• Semimature Dendritic Cells Tolerance and CD8 T Cell Immunity by Simultaneous Induction of CD4 T Cell

  2005cites this paper
• Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination

  2005cites this paper
• Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.

  2005cites this paper
• Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation

  2005cites this paper
• ISG15: a ubiquitin-like enigma.

  2005cites this paper
• Interferon‐γ: an overview of signals, mechanisms and functions

  2004cites this paper
• Genome-Wide Analysis of Molecular Changes in IL-12-Induced Control of Mammary Carcinoma via IFN-γ-Independent Mechanisms1

  2004cites this paper
• ISG15: the immunological kin of ubiquitin.

  2004cites this paper
• Modulation of Immune Functions by Foods

  2004cites this paper
• KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production1

  2003cites this paper
• Mouse B7-H3 induces antitumor immunity

  2003cites this paper
• Suppressor of cytokine signalling gene expression is elevated in breast carcinoma

  2003cites this paper
• Infection and cancer: the common vein.

  2003cites this paper
• Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.

  2002cites this paper
• Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature

  2002cites this paper
• Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNgamma-secreting rat glioma cells.

  2002cites this paper
• Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.

  2002cites this paper
• Intratumoral delivery of an interferon gamma retrovirus-producing cells inhibits growth of a murine melanoma by a non-immune mechanism.

  2001cites this paper
• Vaccination with T Cell-Defined Antigens: Biological Basis and Clinical Applications

  2001cites this paper
• Tissue granuloma structure‐function in experimental visceral leishmaniasis

  2001cites this paper
• Vaccination with T cell-defined antigens: biological basis and clinical applications.

  2001cites this paper
• Genetic disruption of host interferon-γ drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase

  2001cites this paper
• Use of Human Recombinant Antibodies to the Marker of Angiogenesis Ed-B in Cancer Therapy

  2001cites this paper